共 14 条
[1]
XU Q F,FANG X L,CHEN D F.Pharmacokinetics and bioavail-ability of ginsenoside Rb1 and Rg1 fromPanax notoginsengin rats. Journal of Ethnopharmacology . 2003
[2]
XU Q F,FANG X L,CHEN D F,et al.Studies on formulations ofPanax notoginsenosidesfor intranasal administration. Acta PharmSin(药学学报) . 2003
[3]
WANG X Y,CHEN J,ZHANG J T.Effect of ginsenoside Rg1 onlearning and memory impairment induced by-βapandits mechanism ofaction. Acta Pharm Sin(药学学报) . 2001
[4]
KUBLIK H,VIDGIEN M T.Nasal delivery systems and their effect ondeposition and absorption. Advanced Drug Delivery Reviews . 1998
[5]
LISBETH I.Nasal drug delivery:new developments and strategies. Drug Discovery Today . 2002
[6]
LI Q F,GUO X B.30 cases of Alzheimer therapy effect of Qishenglitablet. Fujian J Tradit Clin Med(福建中医药) . 2003
[7]
TONG Y W,JIN F,HUANG A N.Laboratory investigation of scopo-lamine hydrobromide nasal spary. Strait Pharm J(海峡药学) . 2004
[8]
SHEN L H,ZHANG J T.Ginsenoside Rg1 increases the survival rateof hippocampal neural stem cells and improves learning and memory ingerbils suffered from transient global ischemia. Centr South Pharm(中南药学) . 2004
[9]
ANWAR A H.Intranasal drug delivery. Advanced Drug Delivery Reviews . 1998
[10]
JIANG X G,CUI J B,FANG X L,et al.Toxicity of drugs on nasalmucocilia and the method of its evaluation. Acta Pharm Sin(药学学报) . 1995